The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life

Mostrar otras versiones (1)

BACKGROUND: Depression is a leading cause of disability worldwide and depressive symptoms are common in later life. Observational evidence suggests that depression is more prevalent among people with high plasma homocysteine (tHcy), but the results of randomized trials to date have been unable to sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Ford, Andrew H, Flicker, Leon, McCaul, Kieran, van Bockxmeer, Frank, Hegarty, Sarah, Hirani, Varsha, Fenner, Stephen, Almeida, Osvaldo P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822769/
https://www.ncbi.nlm.nih.gov/pubmed/20096138
http://dx.doi.org/10.1186/1745-6215-11-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822769/
https://www.ncbi.nlm.nih.gov/pubmed/20096138
http://dx.doi.org/10.1186/1745-6215-11-8

Ejemplares similares